- Research Tracker
- Evidence-gap maps
- Overactive Bladder
Which non-drug approaches have been tested for Overactive Bladder, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.
Evidence-gap matrix
Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.
| Intervention group | Fatigue and energy | Post-exertional symptoms | Cognition | Mood, anxiety and wellbeing | Pain | Sleep | Physical function and exercise capacity | Heart rate, blood pressure and autonomic | Breathing and lung function | Quality of life | Weight and metabolic markers | Inflammation and other biomarkers | Symptom severity and disease activity | Clinical events, survival and healthcare use | Feasibility, adherence and safety | Not classified |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exercise and physical activity | · | · | · | 2 | 2 | · | 2 | · | · | 1 | · | · | 7 | · | 3 | 2 |
| Rehabilitation and therapy services | · | · | · | · | · | · | 1 | · | · | 2 | · | · | 2 | · | 1 | · |
| Mind-body and psychological approaches | · | · | · | 1 | 1 | 1 | · | 1 | · | 1 | 2 | 1 | 62 with results | · | 1 | 2 |
| Cognitive training and education | · | · | · | · | · | · | · | · | · | 1 | · | · | 2 | · | 21 with results | 2 |
| Diet, fasting and nutrition | · | · | · | · | · | · | · | · | · | 1 | 1 | · | 1 | · | · | · |
| Neuromodulation and electrical stimulation | · | · | · | · | 2 | · | · | 1 | · | 5 | · | 3 | 253 with results | 2 | 2 | 101 with results |
| Oxygen, light, temperature and manual therapies | · | · | · | 1 | 1 | · | · | 1 | · | 1 | · | · | 12 | · | 1 | 5 |
| Supplements and nutraceuticals | · | · | · | · | · | · | 1 | · | · | · | · | 1 | 1 | · | · | 6 |
| Other devices and digital tools | · | · | · | 1 | 1 | · | · | · | · | · | · | · | 1 | · | · | 11 with results |
| Care delivery and health services | · | · | · | 1 | 1 | · | · | · | · | · | · | · | · | · | · | · |
| Other behavioural, not yet classified | · | · | · | · | 2 | · | · | · | · | 1 | · | · | 111 with results | · | 3 | 143 with results |
The table scrolls sideways: 16 outcome columns.
No trials found for this condition in: Breathing and respiratory training; Sleep and circadian approaches.
Where the gaps are
Outcomes not found as a primary outcome in a group's trials
- Among the 8 trials of supplements and nutraceuticals found, none used quality of life as a primary outcome (11 trials of other approaches did).
- Among the 8 trials of supplements and nutraceuticals found, none used pain as a primary outcome (10 trials of other approaches did).
- Among the 47 trials of neuromodulation and electrical stimulation found, none used mood, anxiety and wellbeing as a primary outcome (6 trials of other approaches did).
- Among the 8 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (6 trials of other approaches did).
- Among the 17 trials of oxygen, light, temperature and manual therapies found, none used inflammation and other biomarkers as a primary outcome (5 trials of other approaches did).
- Among the 11 trials of exercise and physical activity found, none used inflammation and other biomarkers as a primary outcome (5 trials of other approaches did).
- Among the 47 trials of neuromodulation and electrical stimulation found, none used physical function and exercise capacity as a primary outcome (4 trials of other approaches did).
- Among the 17 trials of oxygen, light, temperature and manual therapies found, none used physical function and exercise capacity as a primary outcome (4 trials of other approaches did).
- Among the 10 trials of mind-body and psychological approaches found, none used physical function and exercise capacity as a primary outcome (4 trials of other approaches did).
- Among the 11 trials of exercise and physical activity found, none used heart rate, blood pressure and autonomic as a primary outcome (3 trials of other approaches did).
- Among the 8 trials of supplements and nutraceuticals found, none used heart rate, blood pressure and autonomic as a primary outcome (3 trials of other approaches did).
Questions studied but with no results posted
- Oxygen, light, temperature and manual therapies × symptom severity and disease activity: 12 trials registered, none with results posted (4 still recruiting)
- Exercise and physical activity × symptom severity and disease activity: 7 trials registered, none with results posted (1 still recruiting)
- Neuromodulation and electrical stimulation × quality of life: 5 trials registered, none with results posted (2 still recruiting)
- Exercise and physical activity × feasibility, adherence and safety: 3 trials registered, none with results posted
- Neuromodulation and electrical stimulation × inflammation and other biomarkers: 3 trials registered, none with results posted
Design a trial with DecenTrial (beta) Fund a component of this work
A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.
Most-studied approaches for Overactive Bladder
Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page
How outcomes are grouped
Each trial's primary outcome measures are sorted into domains by keyword rules. 38 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).
Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.